Fibrocell Science, Inc. Forms 3, 4 and 5: Stock Options
Statements of beneficial ownership filed with the SEC by officers, directors and 10% owners: 12 rows in 2015. Transaction codes are the SEC's. Shares and prices are split-adjusted; the as-filed figure is underneath.
- 2015-06-24: Reporting owner Swirsky Douglas J; Form 4; Security Option to Purchase Common Stock; Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
- 2015-06-24: Reporting owner Moore Kelvin; Form 4; Security Option to Purchase Common Stock; Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
- 2015-06-24: Reporting owner St.Clare Christine; Form 4; Security Option to Purchase Common Stock; Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
- 2015-06-24: Reporting owner Mazur Marc; Form 4; Security Option to Purchase Common Stock; Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
| Transaction date | Reporting owner | Form | Security | Transaction | Shares | Price | Price that day | Filing |
|---|---|---|---|---|---|---|---|---|
| 2015-06-24 | Swirsky Douglas J Director | 4 | Option to Purchase Common Stock Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +36,000 36,000 owned after | $5.44 exercise price | 2015-06-25 | |
| 2015-06-24 | Moore Kelvin Director | 4 | Option to Purchase Common Stock Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +36,000 36,000 owned after | $5.44 exercise price | 2015-06-25 | |
| 2015-06-24 | St.Clare Christine Director | 4 | Option to Purchase Common Stock Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +36,000 36,000 owned after | $5.44 exercise price | 2015-06-25 | |
| 2015-06-24 | Mazur Marc Director | 4 | Option to Purchase Common Stock Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +36,000 36,000 owned after | $5.44 exercise price | 2015-06-25 | |
| 2015-06-24 | Smith Marcus E. Director | 4 | Option to Purchase Common Stock Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +36,000 36,000 owned after | $5.44 exercise price | 2015-06-25 | |
| 2015-06-24 | Kirk Julian P. Director | 4 | Option to Purchase Common Stock Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +36,000 36,000 owned after | $5.44 exercise price | 2015-06-25 | |
| 2015-06-01 | Marino Michael F III Officer (SVP and General Counsel) | 4 | Option to Purchase Common Stock Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +220,000 220,000 owned after | $4.76 exercise price | 2015-06-02 | |
| 2015-03-20 holding as of filing | Goldan Keith A. Officer (SVP and CFO) | 3 | Option to Purchase Common Stock Derivative · Direct | Holding | $5.35 exercise price | 2015-03-20 | ||
| 2015-01-26 | Pernock David Director, Officer (Chairman and CEO) | 4 | Option to Purchase Common Stock Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +270,000 270,000 owned after | $3.35 exercise price | 2015-01-28 | |
| 2015-01-20 | Maslowski John Michael Officer (VP, Scientific Affairs) | 4 | Option to Purchase Common Stock Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +100,000 100,000 owned after | $3.53 exercise price | 2015-01-22 | |
| 2015-01-20 | Sheroff Robert James Officer (VP, Technical Operations) | 4 | Option to Purchase Common Stock Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +40,000 40,000 owned after | $3.53 exercise price | 2015-01-22 | |
| 2015-01-20 | Smith Kimberly M. Officer (Interim CFO/Treas/Secy) | 4 | Stock Options (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +35,000 35,000 owned after | $3.53 exercise price | 2015-01-22 |